Biotech

All Articles

OS Treatments refiles $6M IPO to finance HER2 medication, preclinical ADCs

.Operating system Therapies will provide on the NYSE American supply exchange today through a $6.4 t...

ALX's fizzling CD47 action cost sends inventory spiraling down

.ALX Oncology's stage 2 stomach cancer cells response fee has deteriorated. After finding its CD47 b...

Ionis axes eye disease from targets of Roche-partnered prospect after information dissatisfy

.An Additional of Ionis Pharmaceuticals' essential midphase readouts has fallen short of expectation...

Biogen's chief executive officer pointed out no high-risk sell 2023. He prepares to be daring

.While Biogen's pharma peers are searching for late-stage properties along with little threat, CEO C...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Bio has been a biotech in search of a pipeline after it ditched its own lead possessions ove...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually restored civil rights to a very early Alzheimer's disease program to Denali Reh...

Takeda touches brand new mind of US oncology company-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings and...

Vertex, hammered by AATD once again, drops 2 possessions on throw away stack

.Tip's attempt to alleviate a rare hereditary disease has actually reached another misfortune. The b...

Vir increases 3 T-cell engagers coming from Sanofi, lays off 25% of workers

.Vir Medical's second-quarter earnings report had not been except big information. The business acce...

Galapagos stops CAR-T tissue therapy hearing over Parkinsonism case

.Galapagos has stopped application in a test of a BCMA-directed CAR-T tissue treatment, pumping the ...